Published

Plain Language Summary Publication: Low-dose psilocybin in short-lasting unilateral neuralgiform headache attacks: Results from an open-label phase Ib ascending dose study

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Headache The Journal of Head and Face Pain
Date: 2024-10-09
Source: OpenAlex
DOI: 10.1111/head.14846
PubMed: 39382331

Authors

James Rucker Matthew Butler Sadie Hambleton Catherine Bird Mathieu Seynaeve Sanjay Cheema Kete Campbell-Coker Carolina Maggio Fiona Dunbar Giorgio Lambru Manjit Matharu

Watch author

Derived topics and classifications

psilocybin Chronic Pain Headache / Migraine Pharmacology Mechanism of Action Clinical Trial Clinical Trial

Citation graph

0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

Indexed papers citing this DOI

Plain Language Summary Publication: Low-dose psilocybin in short-lasting unilateral neuralgiform headache attacks: Results from an open-label phase Ib ascending dose study2024-10-09

Related papers

An Open-Label Trial Protocol to Test Menstrual Cycle Effects and Tolerance to Low-Dose Psilocybin in Healthy Menstruating Persons.Pharmacology · 2026-08-10 Impact of Psilocybin on Motor Function in Healthy Participants: A Phase 1, Randomised, Triple-Blind, Dose-Finding Study.CNS drugs · 2026-08-07 Assessing Canadian Policy Readiness for Psychedelic-Assisted Therapy in Cancer CareUnknown journal · 2026-08-17 Ayahuasca and Salvia divinorum as contrasting modes of consciousness reorganization: Implications for psychedelic-assisted psychotherapyJournal of Psychedelic Studies · 2026-08-13 Psilocybin-Assisted Therapy in Psychiatry: A Narrative Clinical Review of Mechanisms, Therapeutic Applications, and Emerging Evidence (2025-2026)Journal of Clinical Medicine · 2026-08-12 Psychedelic Therapy for DepressionUnknown journal · 2026-08-11 Feasibility and Tolerability of Psilocybin for Phantom Limb Pain.The journal of pain · 2026-08-07 Psilocybin-assisted therapy for treatment-resistant major depressive disorder in a public healthcare setting: a randomized controlled trial.Nature medicine · 2026-08-06